Harbour Investments, Inc. Laboratory Corp Of America Holdings Transaction History

Harbour Investments, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 16, 2024	BUY	$197.69 - $227.29 $7,116 - $8,182	36 Added 2.98%	1,246 $283,000
Q3 2023 Nov 15, 2023	BUY	$201.05 - $221.7 $1,608 - $1,773	8 Added 0.67%	1,210 $243,000
Q2 2023 Aug 14, 2023	SELL	$211.93 - $241.33 $1,059 - $1,206	-5 Reduced 0.41%	1,202 $290,000
Q1 2023 May 15, 2023	BUY	$213.32 - $257.83 $43,943 - $53,112	206 Added 20.58%	1,207 $276,000
Q4 2022 Feb 15, 2023	SELL	$203.72 - $248.97 $1,833 - $2,240	-9 Reduced 0.89%	1,001 $235,000
Q2 2022 Aug 15, 2022	SELL	$213.86 - $277.87 $22,669 - $29,454	-106 Reduced 9.5%	1,010 $237,000
Q4 2021 Feb 16, 2022	SELL	$271.6 - $314.21 $156,713 - $181,299	-577 Reduced 34.08%	1,116 $351,000
Q3 2021 Nov 15, 2021	BUY	$274.82 - $308.34 $31,879 - $35,767	116 Added 7.36%	1,693 $477,000
Q2 2021 Aug 16, 2021	BUY	$251.87 - $278.14 $28,965 - $31,986	115 Added 7.87%	1,577 $435,000
Q1 2021 Aug 17, 2021	BUY	$204.88 - $255.03 $298,715 - $371,833	1,458 Added 36450.0%	1,462 $373,000
Q1 2021 May 12, 2021	BUY	$204.88 - $255.03 $819 - $1,020	4 New	4 $1,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.